Gynecologic Oncology
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Sleep is not the answer to fighting cancer fatigue
-
Clinical Briefs in Primary Care supplement
-
Breast Cancer Risk in Finnish Women Using Estrogen-Only Therapy
Lyytinen and colleagues from Helsinki reported the results of a cohort study assessing the risk of breast cancer in postmenopausal Finnish women using oral, transdermal, and vaginal estrogen products containing either estradiol or estriol. -
Decline in Breast Cancer and Reduced Use of Hormone Therapy
Ravdin and colleagues from the University of Texas M.D. Anderson Cancer Center reported a 7% decrease (14,000 fewer cases) in the incidence of breast cancer in 9 regions of the U.S. in 2003. -
Pharmacology Watch: Breast Cancer Rates Have Dropped Since WHI of 2002
Herbal Supplements to Treat Vasomotor Symptoms; Bisphosphonates to Treat LBD, After 5 Years?; FDA Actions -
Phenotypic Differences between Male Physicians, Surgeons, and Film Stars: Comparative Study
The investigators enticed 14 male surgeons and 16 male physicians (internal medicine and sub-specialists) to submit recent photographs of themselves to the investigators and to indicate how tall they were. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Several important papers have been published in the last 2 months, none more important than the realization that breast cancer rates have dropped precipitously since the publication of the Women's Health Initiative (WHI) in 2002. -
Defining Prognostic Features in Triple-Negative Breast Cancer
Breast cancers that are "triple-negative" (ie, ER, PR, HER2-negative) are considered high risk, yet there remains variability, with some demonstrating less malignant features than others.